| pubmed-article:15709195 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15709195 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:15709195 | lifeskim:mentions | umls-concept:C0039286 | lld:lifeskim |
| pubmed-article:15709195 | lifeskim:mentions | umls-concept:C1176289 | lld:lifeskim |
| pubmed-article:15709195 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:15709195 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:15709195 | lifeskim:mentions | umls-concept:C1517132 | lld:lifeskim |
| pubmed-article:15709195 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15709195 | pubmed:dateCreated | 2005-2-14 | lld:pubmed |
| pubmed-article:15709195 | pubmed:abstractText | Farnesyltransferase (FTase) inhibitors, which were designed to inhibit oncogenic Ras, act synergistically with tamoxifen in preclinical breast cancer models. We studied the safety and toxicity of tipifarnib in combination with tamoxifen in metastatic breast cancer. The pharmacokinetics and pharmacodynamics of tipifarnib were also assessed. | lld:pubmed |
| pubmed-article:15709195 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15709195 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15709195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15709195 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15709195 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15709195 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:VenzonDavidD | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:BalisFrank... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:ZujewskiJoAnn... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:ClarkGeoffG | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:ChowCatherine... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:WidemannBrigi... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:Eng-WongJenni... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:LebowitzPeter... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:JayaprakashNa... | lld:pubmed |
| pubmed-article:15709195 | pubmed:author | pubmed-author:GantzSusan... | lld:pubmed |
| pubmed-article:15709195 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15709195 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15709195 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15709195 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15709195 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15709195 | pubmed:pagination | 1247-52 | lld:pubmed |
| pubmed-article:15709195 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:meshHeading | pubmed-meshheading:15709195... | lld:pubmed |
| pubmed-article:15709195 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15709195 | pubmed:articleTitle | A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. | lld:pubmed |
| pubmed-article:15709195 | pubmed:affiliation | Medical Oncology Clinical Research Unit, National Cancer Institute/NIH, 9000 Rockville Pike, Bethesda, MD 20892, USA. peter.lebowitz@nih.gov | lld:pubmed |
| pubmed-article:15709195 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15709195 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15709195 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15709195 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15709195 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15709195 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15709195 | lld:pubmed |
